Cheryl L. Willman, MD¹, Huining Kang, PhD^1*, Richard C. Harvey, PhD², I-Ming Chen, DVM, MS^3*, Charles Mullighan, MD^4*, James R. Downing, MD^5*, Mary V. Relling, PharmD⁴, Jinghui Zhang, PhD^6*, Daniela Gerhard, PhD^7*, Malcolm Smith, MD, PhD^8*, Kevin K. Dobbin, PhD^9*, Gregory Reaman, MD¹⁰ and Stephen Hunger, MD¹¹

¹UNM Cancer Research Facility, University of New Mexico Cancer Research and Treatment Center, Albuquerque, NM
²University of New Mexico School of Medicine, Albuquerque, NM
³Cancer Research Facility, University of New Mexico Cancer Research and Treatment Center, Albuquerque, NM
⁴St. Jude Children's Research Hospital, Memphis, TN
⁵Administration, St. Jude Children's Research Hospital, Memphis, TN
⁶National Cancer Institute, National Institutes of Health, Rockville, MD
⁷National Cancer Institute, National Institutes of Health, Bethesda, MD
⁸Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁹Biometric Research Branch and Cancer Diagnosis Program, National Cancer Institute, National Institutes of Health, Bethesda, MD
¹⁰Children's National Medical Center, Washington, DC
¹¹Pediatric Heme/Onc/BMT, Univ of Colorado College of Medicine, Aurora, CO

Kevin Shannon, MD

University of California School of Medicine - San Francisco, San Francisco, CA

Stephan A. Grupp, MD, PhD

Abramson Pediatric Research Center, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA